TY  - JOUR
AU  - Mazoteras-Pardo, Victoria
AU  - Becerro-De-Bengoa-Vallejo, Ricardo
AU  - Losa-Iglesias, Marta Elena
AU  - Martínez-Jiménez, Eva María
AU  - Calvo-Lobo, César
AU  - Romero-Morales, Carlos
AU  - López-López, Daniel
AU  - Palomo-López, Patricia
PY  - 2020
DA  - 2020/7/24
TI  - QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study
JO  - J Med Internet Res
SP  - e19781
VL  - 22
IS  - 7
KW  - blood pressure
KW  - hypertension
KW  - type 2 diabetes
KW  - mobile applications
KW  - software validation
AB  - Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension. 
SN  - 1438-8871
UR  - http://www.jmir.org/2020/7/e19781/
UR  - https://doi.org/10.2196/19781
UR  - http://www.ncbi.nlm.nih.gov/pubmed/32706672
DO  - 10.2196/19781
ID  - info:doi/10.2196/19781
ER  -